Table 2 Association of LCN2 expression with the features of OSCC patients.

From: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3

Characteristics

LCN2 expression

P value

High (%)

Low (%)

Age

≤40

11 (42.31)

15 (57.69)

 

>40

13 (33.33)

26 (66.67)

0.4705

Gender

Male

14 (36.84)

24 (63.16)

 

Female

10 (37.04)

17 (62.96)

0.9874

Differentiation

Well

6 (22.22)

21 (77.78)

 

Moderate

8 (36.36)

14 (63.64)

 

Poor

10 (62.50)

6 (37.50)

0.0087

Lymphatic metastasis

No

7 (21.88)

25 (78.12)

 

Yes

17 (51.52)

16 (48.48)

0.0128

Clinical stage (T)

1

2 (11.76)

15 (88.24)

 

2

9 (40.91)

13 (59.09)

 

3

8 (50.00)

8 (50.00)

 

4

5 (50.00)

5 (50.00)

0.0233

  1. Lcn2 positive 24 (36.92%), negative 41 (63.08%)
Back to article page